CODAGENIX INC.
6Patents
6Active
6Granted
44Portfolio score
Filing activity: Sep 22, 2017 → Jun 28, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10808012B2 | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes | Chemistry; Metallurgy | 4 | Active |
| US12168049B2 | Attenuated flaviviruses | Emerging Cross-Sectional Technologies | 0 | Active |
| US11390651B2 | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes | Chemistry; Metallurgy | 0 | Active |
| US12178869B2 | Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer | Emerging Cross-Sectional Technologies | 0 | Active |
| US11793870B2 | Live attenuated strains of foot and mouth disease modified by deoptimization and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12054519B2 | Vaccine candidates for human respiratory syncytial virus (RSV) having attenuated phenotypes | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.